AMERIGROUP Corp (AGP)
A multi-state managed healthcare company focused on serving people who receive healthcare benefits through publicly sponsored programs, including Medicaid, SCHIP, FamilyCare and SNP.
Recs
Presents a compelling value while everyone is afraid of government involvement in health care as a whole.
If legislation is passed, more people forced into coverage should boost AGP's numbers as more small businesses seek plans for their employees.. If legislation doesn't pass, AGP is still the same company as it was before except discounted.
Recs
If analysts see downside, I see upside.
Recs
Value play, Obamacare play.
Recs
No debt and $15.65/share cash,the price for AGP is around $9.00. That puts the true forward PE around 3. The reason for the loss last year was a settlement of $225M that should be over. I would like to see a dividend from this stock, but not likely going to happen.
Recs
Amerigroup manages Medicaid programs for a number of states.
They have done a reasonably good job at this, so more states will turn to this company to keep their Medicaid costs down. Keeping these costs down will be especially important during this current recession which is expected to last at least 2-3 years. Sell half at $40.
Recs
How's this for an investment thesis: Unemployment up, Medicaid Up, AmeriGroup Up.
Recs
PLEASE SEE AVAV BLOG
11/20/8 DAILY FOOL - ENTIRE IBD
1 0F 33 MEDICAL
PUBLIC PROGRAMS EX MEDICAID
Recs
$20 or below
Recs
The sky is falling.Be careful and don't let it hit you in the head. You may want to give this one that 360 look as it slides this wall. RED!,my favorite color. I hope the moon falls and hits the ground.
Recs
Low PE, Low debt, and good revenue growth. This is what I look for.
Recs
health care
Recs
breaking out of cup with handle pattern that's part of a larger two-year pattern; solid EPS and sales growth past 4 qtrs. bucking market's downtrend, rising on high volume and holding above 10-wk avg. defense sector in uncertain market
Recs
Wonda GARP 01/09/2007. Shows cup/saucer with handle pattern. SMR =55 and C, Composite 93, A/D 19, RS=90, GR=20, Data Graph=87, EPS Rank=80, % off high = -2.9%, 5yr Stability EPS = 33, P/E =18, y/y margin increase 4.1%, ROE =10%
Recs
I love this company.You young people should have 6 stars on this guy.I have made alot of jack of of it,and bought it again this year for $24,and look at it now.I might sell it when it gets to $40
Recs
Model Stock,can run on auto cruse to porform.
Recs
Good historical growth in a solid industry. Good short and long-term prospects - target price of $43 one year from now.
Recs
Good long-term prospects for this stock and sector.
Recs
solid advise worth the capital
Recs
What a great young and upcoming company......slowly working towards their goals and working for what is good and rightous.....
Recs
Operating in a regulated market, sizeable portion of Amerigroup’s revenue comes from government sponsored healthcare programs. With the increasing population of U.S.A. and the rising number of baby boomers, AmeriGroup is all set to milk the growth opportunities available in the industry. Revenues of the company are estimated to rise primarily due to buoyant membership. Total membership in the first quarter surged by 21.2 percent as compare to the same period in 2006. The group has successfully entered into regions like Tennessee, Cincinnati, Maryland and Ohio, and further plans to enter the Georgia region, including Atlanta and the North, East and Southeast regions.
Health care industry has an encouraging outlook for the future and reports a strong E.P.S. escalation. Tax breaks which have been proposed for independent health insurance for families and individuals outside the span of employment are likely to boost the private healthcare segment. The prospects of the industry face a risk from change of control of democratic congress; however, at least through 2008 there can be no changes, as the plans of democratic congress could be blocked by Presidents vetoes.
Robust membership of Ameri Group lifted the revenues for the Q1 ended March 2007 by 23.5 percent to $832 million over the previous year’s quarter. The organic premium revenue growth of the company for the fiscal year 2007 is estimated to be slightly above 30 percent because of additional new products and markets. With the price to earnings ratio placed well below the industry levels, AGP seems to be a healthy investment proposition.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 28 1 2 Next »